RESUMEN
In the mouse embryonic forebrain, developmentally distinct oligodendrocyte progenitor cell populations and their progeny, oligodendrocytes, emerge from three distinct regions in a spatiotemporal gradient from ventral to dorsal. However, the functional importance of this oligodendrocyte developmental heterogeneity is unknown. Using a genetic strategy to ablate dorsally derived oligodendrocyte lineage cells (OLCs), we show here that the areas in which dorsally derived OLCs normally reside in the adult central nervous system become populated and myelinated by OLCs of ventral origin. These ectopic oligodendrocytes (eOLs) have a distinctive gene expression profile as well as subtle myelination abnormalities. The failure of eOLs to fully assume the role of the original dorsally derived cells results in locomotor and cognitive deficits in the adult animal. This study reveals the importance of developmental heterogeneity within the oligodendrocyte lineage and its importance for homeostatic brain function.
Asunto(s)
Encéfalo , Linaje de la Célula , Oligodendroglía , Animales , Oligodendroglía/fisiología , Ratones , Encéfalo/citología , Encéfalo/embriología , Linaje de la Célula/fisiología , Diferenciación Celular/fisiología , Ratones Transgénicos , Vaina de Mielina/metabolismo , Vaina de Mielina/fisiologíaRESUMEN
Aging is a major risk factor for several neurodegenerative diseases and is associated with cognitive decline. In addition to affecting neuronal function, the aging process significantly affects the functional phenotype of the glial cell compartment, comprising oligodendrocyte lineage cells, astrocytes, and microglia. These changes result in a more inflammatory microenvironment, resulting in a condition that is favorable for neuron and synapse loss. In addition to facilitating neurodegeneration, the aging glial cell population has negative implications for central nervous system remyelination, a regenerative process that is of particular importance to the chronic demyelinating disease multiple sclerosis. This review will discuss the changes that occur with aging in the three main glial populations and provide an overview of the studies documenting the impact these changes have on remyelination.
Asunto(s)
Enfermedades Desmielinizantes , Vaina de Mielina , Humanos , Neuroglía , Sistema Nervioso Central/fisiología , Regeneración Nerviosa , Oligodendroglía/fisiologíaRESUMEN
The rates and patterns of somatic mutation in normal tissues are largely unknown outside of humans1-7. Comparative analyses can shed light on the diversity of mutagenesis across species, and on long-standing hypotheses about the evolution of somatic mutation rates and their role in cancer and ageing. Here we performed whole-genome sequencing of 208 intestinal crypts from 56 individuals to study the landscape of somatic mutation across 16 mammalian species. We found that somatic mutagenesis was dominated by seemingly endogenous mutational processes in all species, including 5-methylcytosine deamination and oxidative damage. With some differences, mutational signatures in other species resembled those described in humans8, although the relative contribution of each signature varied across species. Notably, the somatic mutation rate per year varied greatly across species and exhibited a strong inverse relationship with species lifespan, with no other life-history trait studied showing a comparable association. Despite widely different life histories among the species we examined-including variation of around 30-fold in lifespan and around 40,000-fold in body mass-the somatic mutation burden at the end of lifespan varied only by a factor of around 3. These data unveil common mutational processes across mammals, and suggest that somatic mutation rates are evolutionarily constrained and may be a contributing factor in ageing.
Asunto(s)
Longevidad , Tasa de Mutación , Animales , Humanos , Longevidad/genética , Mamíferos/genética , Mutagénesis/genética , MutaciónRESUMEN
Myelin sheaths, by supporting axonal integrity and allowing rapid saltatory impulse conduction, are of fundamental importance for neuronal function. In response to demyelinating injuries in the central nervous system (CNS), oligodendrocyte progenitor cells (OPCs) migrate to the lesion area, proliferate and differentiate into new oligodendrocytes that make new myelin sheaths. This process is termed remyelination. Under specific conditions, demyelinated axons in the CNS can also be remyelinated by Schwann cells (SCs), the myelinating cell of the peripheral nervous system. OPCs can be a major source of these CNS-resident SCs-a surprising finding given the distinct embryonic origins, and physiological compartmentalization of the peripheral and central nervous system. Although the mechanisms and cues governing OPC-to-SC differentiation remain largely undiscovered, it might nevertheless be an attractive target for promoting endogenous remyelination. This article will (i) review current knowledge on the origins of SCs in the CNS, with a particular focus on OPC to SC differentiation, (ii) discuss the necessary criteria for SC myelination in the CNS and (iii) highlight the potential of using SCs for myelin regeneration in the CNS.
Asunto(s)
Sistema Nervioso Central/metabolismo , Vaina de Mielina/metabolismo , Remielinización/fisiología , Diferenciación Celular , Humanos , Esclerosis Múltiple/metabolismo , Esclerosis Múltiple/patología , Oligodendroglía/citología , Oligodendroglía/metabolismo , Células de Schwann/citología , Células de Schwann/metabolismo , Células de Schwann/trasplante , Células Madre/citología , Células Madre/metabolismoRESUMEN
Like many adult stem cell populations, the capacity of oligodendrocyte progenitor cells (OPCs) to proliferate and differentiate is substantially impaired with aging. Previous work has shown that tissue-wide transient expression of the pluripotency factors Oct4, Sox2, Klf4 and c-Myc extends lifespan and enhances somatic cell function. Here we show that just one of these factors, c-Myc, is sufficient to determine the age state of OPC: c-Myc expression in aged OPCs drives their functional rejuvenation, while its inhibition in neonatal OPCs induces an aged-like phenotype, as determined by in vitro assays and transcriptome analysis. Increasing c-Myc expression in aged OPCs in vivo restores their proliferation and differentiation capacity, thereby enhancing regeneration in an aged central nervous system environment. Our results directly link Myc to cellular activity and cell age state, with implications for understanding regeneration in the context of aging, and provide important insights into the biology of stem cell aging.
Asunto(s)
Células Madre Adultas , Células Precursoras de Oligodendrocitos , Células Precursoras de Oligodendrocitos/fisiología , Sistema Nervioso Central , Células Madre/metabolismo , Diferenciación Celular/genéticaRESUMEN
OBJECTIVE: To establish a rigorous, expert-led, evidence-based approach to the evaluation of licensed drugs for repurposing and testing in clinical trials of people with progressive multiple sclerosis (MS). METHODS: We long-listed licensed drugs with evidence of human safety, blood-brain barrier penetrance and demonstrable efficacy in at least one animal model, or mechanistic target, agreed by a panel of experts and people with MS to be relevant to the pathogenesis of progression. We systematically reviewed the preclinical and clinical literature for each compound, condensed this into a database of summary documents and short-listed drugs by scoring each one of them. Drugs were evaluated for immediate use in a clinical trial, and our selection was scrutinised by a final independent expert review. RESULTS: From a short list of 55 treatments, we recommended four treatments for immediate testing in progressive MS: R-α-lipoic acid, metformin, the combination treatment of R-α-lipoic acid and metformin, and niacin. We also prioritised clemastine, lamotrigine, oxcarbazepine, nimodipine and flunarizine. CONCLUSIONS: We report a standardised approach for the identification of candidate drugs for repurposing in the treatment of progressive MS.
Asunto(s)
Reposicionamiento de Medicamentos , Esclerosis Múltiple Crónica Progresiva/tratamiento farmacológico , Animales , Evaluación de Medicamentos , HumanosRESUMEN
The age-related failure to produce oligodendrocytes from oligodendrocyte progenitor cells (OPCs) is associated with irreversible neurodegeneration in multiple sclerosis (MS). Consequently, regenerative approaches have significant potential for treating chronic demyelinating diseases. Here, we show that the differentiation potential of adult rodent OPCs decreases with age. Aged OPCs become unresponsive to pro-differentiation signals, suggesting intrinsic constraints on therapeutic approaches aimed at enhancing OPC differentiation. This decline in functional capacity is associated with hallmarks of cellular aging, including decreased metabolic function and increased DNA damage. Fasting or treatment with metformin can reverse these changes and restore the regenerative capacity of aged OPCs, improving remyelination in aged animals following focal demyelination. Aged OPCs treated with metformin regain responsiveness to pro-differentiation signals, suggesting synergistic effects of rejuvenation and pro-differentiation therapies. These findings provide insight into aging-associated remyelination failure and suggest therapeutic interventions for reversing such declines in chronic disease.
Asunto(s)
Envejecimiento/fisiología , Sistema Nervioso Central/fisiología , Hipoglucemiantes/farmacología , Metformina/farmacología , Esclerosis Múltiple/terapia , Células Precursoras de Oligodendrocitos/fisiología , Oligodendroglía/fisiología , Animales , Diferenciación Celular , Células Cultivadas , Daño del ADN , Femenino , Humanos , Masculino , Células Precursoras de Oligodendrocitos/efectos de los fármacos , Células Precursoras de Oligodendrocitos/trasplante , Ratas , Rejuvenecimiento , Remielinización , Trasplante de Células MadreRESUMEN
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
RESUMEN
Ageing causes a decline in tissue regeneration owing to a loss of function of adult stem cell and progenitor cell populations1. One example is the deterioration of the regenerative capacity of the widespread and abundant population of central nervous system (CNS) multipotent stem cells known as oligodendrocyte progenitor cells (OPCs)2. A relatively overlooked potential source of this loss of function is the stem cell 'niche'-a set of cell-extrinsic cues that include chemical and mechanical signals3,4. Here we show that the OPC microenvironment stiffens with age, and that this mechanical change is sufficient to cause age-related loss of function of OPCs. Using biological and synthetic scaffolds to mimic the stiffness of young brains, we find that isolated aged OPCs cultured on these scaffolds are molecularly and functionally rejuvenated. When we disrupt mechanical signalling, the proliferation and differentiation rates of OPCs are increased. We identify the mechanoresponsive ion channel PIEZO1 as a key mediator of OPC mechanical signalling. Inhibiting PIEZO1 overrides mechanical signals in vivo and allows OPCs to maintain activity in the ageing CNS. We also show that PIEZO1 is important in regulating cell number during CNS development. Thus we show that tissue stiffness is a crucial regulator of ageing in OPCs, and provide insights into how the function of adult stem and progenitor cells changes with age. Our findings could be important not only for the development of regenerative therapies, but also for understanding the ageing process itself.
Asunto(s)
Células Madre Adultas/patología , Envejecimiento/patología , Sistema Nervioso Central/patología , Células Madre Multipotentes/patología , Nicho de Células Madre , Animales , Animales Recién Nacidos , Recuento de Células , Matriz Extracelular/patología , Femenino , Humanos , Proteínas de la Membrana/antagonistas & inhibidores , Proteínas de la Membrana/metabolismo , Oligodendroglía/patología , Ratas , Nicho de Células Madre/fisiologíaRESUMEN
It is now well-established that the macrophage and microglial response to CNS demyelination influences remyelination by removing myelin debris and secreting a variety of signaling molecules that influence the behaviour of oligodendrocyte progenitor cells (OPCs). Previous studies have shown that changes in microglia contribute to the age-related decline in the efficiency of remyelination. In this study, we show that microglia increase their expression of the proteoglycan NG2 with age, and that this is associated with an altered micro-niche generated by aged, but not young, microglia that can divert the differentiation OPCs from oligodendrocytes into astrocytes in vitro. We further show that these changes in ageing microglia are generated by exposure to high levels of TGFß. Thus, our findings suggest that the rising levels of circulating TGFß known to occur with ageing contribute to the age-related decline in remyelination by impairing the ability of microglia to promote oligodendrocyte differentiation from OPCs, and therefore could be a potential therapeutic target to promote remyelination.
Asunto(s)
Senescencia Celular/fisiología , Microglía/metabolismo , Células Precursoras de Oligodendrocitos/metabolismo , Oligodendroglía/metabolismo , Factor de Crecimiento Transformador beta/farmacología , Factores de Edad , Animales , Animales Recién Nacidos , Diferenciación Celular/fisiología , Células Cultivadas , Senescencia Celular/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/metabolismo , Relación Dosis-Respuesta a Droga , Microglía/efectos de los fármacos , Células Precursoras de Oligodendrocitos/efectos de los fármacos , Oligodendroglía/efectos de los fármacos , Ratas , Ratas Sprague-DawleyRESUMEN
A new sol-gel synthesis route for rare earth (Ce and Pr) alumina hybrid aero- and xerogels is presented which is based on the so-called epoxide addition method. The resulting materials are characterized by TEM, XRD and nitrogen adsorption. The results reveal a different crystallization behavior for the praseodymia/alumina and the ceria/alumina gel. Whereas the first remains amorphous until 875°C, small ceria domains form already after preparation in the second case which grow with increasing calcination temperature. The use of the calcined gels as CO oxidation catalysts was studied in a quartz tube (lab) reactor and in a (slit) microreactor and compared to reference catalysts consisting of the pure rare earth oxides. The Ce/Al hybrid gels exhibit a good catalytic activity and a thermal stability against sintering which was superior to the investigated reference catalyst. In contrast, the Pr/Al hybrid gels show lower CO oxidation activity which, due to the formation of PrAlO3, decreased with increasing calcination temperature.
RESUMEN
Pulsed field gradient (PFG) NMR was used to investigate the self-diffusion of carbon dioxide in alumina stabilized samaria aerogel catalyst, a promising porous catalyst for gas-phase reactions featuring high porosity and high surface area. For diffusion studies, the catalyst was prepared in two sample packing types, macroscopic monoliths (i.e., macroscopic cylindrical particles) and powder beds with particle sizes around 200 µm that are considered for catalytic applications. Studies of diffusion in these samples revealed how macroscopic packing influences the catalyst transport properties. Application of a high magnetic field of 17.6 T in the reported PFG NMR studies enabled diffusion measurements for relatively low carbon dioxide densities in the catalyst samples corresponding to a gas loading pressure of around 0.1 atm. As a result, it was possible to perform diffusion measurements for a large range of carbon dioxide loading pressures between 0.1 and 10 atm. The measured carbon dioxide diffusivities in the beds of catalyst particles are interpreted in the context of a simple diffusion-mediated exchange model previously used for zeolites and other porous materials.